X4 Pharmaceuticals (NASDAQ:XFOR) Price Target Raised to $7.00
X4 Pharmaceuticals (NASDAQ:XFOR – Get Free Report) had its target price hoisted by equities researchers at HC Wainwright from $1.50 to $7.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price target points to a potential upside of 88.17% from the […]
